12,131 followers
RT @FrontOncology: New research: Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patient…
RT @FrontOncology: New research: Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patient…
Frontiers | Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer https://t.co/O1HIaK8uCa
New research: Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer: Introduction Small cell lung cancer (SCLC) is a rapidly growing malignancy with… #oncology htt